Probi AB Financials
| PROB Stock | SEK 347.00 1.00 0.29% |
Probi |
Understanding current and past Probi AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Probi AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Probi AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Probi AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Probi AB. Check Probi AB's Beneish M Score to see the likelihood of Probi AB's management manipulating its earnings.
Probi AB Stock Summary
Probi AB competes with BioGaia AB, CellaVision, Biotage AB, Vitrolife, and RaySearch Laboratories. Probi AB , a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The company was founded in 1991 and is headquartered in Lund, Sweden. Probi AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 164 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0001280355 |
| Business Address | Ideongatan 1A, Lund, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.probi.com |
| Phone | 46 4 62 86 89 20 |
| Currency | SEK - Swedish Kronor |
You should never invest in Probi AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Probi Stock, because this is throwing your money away. Analyzing the key information contained in Probi AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Probi AB Key Financial Ratios
Probi AB's financial ratios allow both analysts and investors to convert raw data from Probi AB's financial statements into concise, actionable information that can be used to evaluate the performance of Probi AB over time and compare it to other companies across industries.| Return On Equity | 0.0304 | |||
| Return On Asset | 0.0211 | |||
| Target Price | 317.8 | |||
| Number Of Employees | 154 | |||
| Beta | 0.51 |
Probi Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Probi AB's current stock value. Our valuation model uses many indicators to compare Probi AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Probi AB competition to find correlations between indicators driving Probi AB's intrinsic value. More Info.Probi AB is regarded fourth in return on equity category among its peers. It also is regarded fourth in return on asset category among its peers reporting about 0.69 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Probi AB is roughly 1.44 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Probi AB's earnings, one of the primary drivers of an investment's value.Probi AB Systematic Risk
Probi AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Probi AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Probi AB correlated with the market. If Beta is less than 0 Probi AB generally moves in the opposite direction as compared to the market. If Probi AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Probi AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Probi AB is generally in the same direction as the market. If Beta > 1 Probi AB moves generally in the same direction as, but more than the movement of the benchmark.
Probi AB November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Probi AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Probi AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Probi AB based on widely used predictive technical indicators. In general, we focus on analyzing Probi Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Probi AB's daily price indicators and compare them against related drivers.
| Downside Deviation | 3.17 | |||
| Information Ratio | 0.056 | |||
| Maximum Drawdown | 44.11 | |||
| Value At Risk | (4.65) | |||
| Potential Upside | 5.02 |
Additional Tools for Probi Stock Analysis
When running Probi AB's price analysis, check to measure Probi AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Probi AB is operating at the current time. Most of Probi AB's value examination focuses on studying past and present price action to predict the probability of Probi AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Probi AB's price. Additionally, you may evaluate how the addition of Probi AB to your portfolios can decrease your overall portfolio volatility.